<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36992456</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">747</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15030747</ELocationID><Abstract><AbstractText>Rhinoviruses (RVs) are major instigators of acute exacerbations of asthma, COPD, and other respiratory diseases. RVs are categorized into three species (RV-A, RV-B, and RV-C), which comprise more than 160 serotypes, making it difficult to develop an effective vaccine. Currently, no effective treatment for RV infection is available. Pulmonary surfactant is an extracellular complex of lipids and proteins that plays a central role in regulating innate immunity in the lung. The minor pulmonary surfactant lipids, palmitoyl-oleoyl-phosphatidylglycerol (POPG) and phosphatidylinositol (PI), are potent regulators of inflammatory processes and exert antiviral activity against respiratory syncytial virus (RSV) and influenza A viruses (IAV). In the current study, we examined the potencies of POPG and PI against rhinovirus A16 (RV-A16) in primary human airway epithelial cells (AECs) differentiated at an air-liquid interface (ALI). After AECs were infected with RV-A16, PI reduced the viral RNA copy number by 70% and downregulated (55-75%) the expression of antiviral (MDA5, IRF7, and IFN-lambda) and CXCL11 chemokine genes. In contrast, POPG only slightly decreased MDA5 (24%) and IRF7 (11%) gene expression but did not inhibit IFN-lambda gene expression or RV-A16 replication in AECs. However, both POPG and PI inhibited (50-80%) IL6 gene expression and protein secretion and CXCL11 protein secretion. PI treatment dramatically attenuated global gene expression changes induced by RV-A16 infection alone in AECs. The observed inhibitory effects were indirect and resulted mainly from the inhibition of virus replication. Cell-type enrichment analysis of viral-regulated genes opposed by PI treatment revealed the PI-inhibited viral induction of goblet cell metaplasia and the virus-induced downregulation of ciliated, club, and ionocyte cell types. Notably, the PI treatment also altered the ability of RV-A16 to regulate the expression of some phosphatidylinositol 4-kinase (<i>PI4K</i>); acyl-CoA-binding, domain-containing (<i>ACBD</i>); and low-density lipoprotein receptor (<i>LDLR</i>) genes that play critical roles in the formation and functioning of replication organelles (ROs) required for RV replication in host cells. These data suggest PI can be used as a potent, non-toxic, antiviral agent for RV infection prophylaxis and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Numata</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sajuthi</LastName><ForeName>Satria</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bochkov</LastName><ForeName>Yury A</ForeName><Initials>YA</Initials><Identifier Source="ORCID">0000-0003-2618-4496</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Everman</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vladar</LastName><ForeName>Eszter K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooney</LastName><ForeName>Riley A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-0921-6943</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhardt</LastName><ForeName>Richard Lee</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Andrew H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Section of Pediatric Pulmonary &amp; Sleep Medicine, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seibold</LastName><ForeName>Max A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voelker</LastName><ForeName>Dennis R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM 118819</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI125357</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI148707</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI104317</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM118819</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL132821</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011663">Pulmonary Surfactants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000623787">Rhinovirus A</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011663" MajorTopicYN="Y">Pulmonary Surfactants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">human phosphatidylinositol 4-kinases</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">primary human airway epithelial cells</Keyword><Keyword MajorTopicYN="N">replication organelle</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36992456</ArticleId><ArticleId IdType="pmc">PMC10055697</ArticleId><ArticleId IdType="doi">10.3390/v15030747</ArticleId><ArticleId IdType="pii">v15030747</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Friedlander S.L., Busse W.W. The role of rhinovirus in asthma exacerbations. J. Allergy Clin. Immunol. 2005;116:267–273. doi: 10.1016/j.jaci.2005.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.06.003</ArticleId><ArticleId IdType="pubmed">16083778</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S., Palmenberg A.C., Gern J.E. Rhinoviruses and Their Receptors. Chest. 2019;155:1018–1025. doi: 10.1016/j.chest.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.12.012</ArticleId><ArticleId IdType="pmc">PMC6533451</ArticleId><ArticleId IdType="pubmed">30659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark P.A.B. Asthma and the Dysregulated Immune Response to Rhinovirus. Am. J. Respir. Crit. Care Med. 2020;202:157–159. doi: 10.1164/rccm.202003-0634ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0634ED</ArticleId><ArticleId IdType="pmc">PMC7365359</ArticleId><ArticleId IdType="pubmed">32240597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.M., Lemanske R.F., Jr., Evans M.D., Vang F., Pappas T., Gangnon R., Jackson D.J., Gern J.E. Human rhinovirus species and season of infection determine illness severity. Am. J. Respir. Crit. Care Med. 2012;186:886–891. doi: 10.1164/rccm.201202-0330OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201202-0330OC</ArticleId><ArticleId IdType="pmc">PMC3530215</ArticleId><ArticleId IdType="pubmed">22923659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamborn I.T., Jing H., Zhang Y., Drutman S.B., Abbott J.K., Munir S., Bade S., Murdock H.M., Santos C.P., Brock L.G., et al. Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J. Exp. Med. 2017;214:1949–1972. doi: 10.1084/jem.20161759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161759</ArticleId><ArticleId IdType="pmc">PMC5502429</ArticleId><ArticleId IdType="pubmed">28606988</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwane M.K., Prill M.M., Lu X., Miller E.K., Edwards K.M., Hall C.B., Griffin M.R., Staat M.A., Anderson L.J., Williams J.V., et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J. Infect. Dis. 2011;204:1702–1710. doi: 10.1093/infdis/jir634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir634</ArticleId><ArticleId IdType="pubmed">22013207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox D.W., Bizzintino J., Ferrari G., Khoo S.K., Zhang G., Whelan S., Lee W.M., Bochkov Y.A., Geelhoed G.C., Goldblatt J., et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am. J. Respir. Crit. Care Med. 2013;188:1358–1364. doi: 10.1164/rccm.201303-0498OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201303-0498OC</ArticleId><ArticleId IdType="pmc">PMC5447292</ArticleId><ArticleId IdType="pubmed">23992536</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A.C., Spiro D., Kuzmickas R., Wang S., Djikeng A., Rathe J.A., Fraser-Liggett C.M., Liggett S.B. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science. 2009;324:55–59. doi: 10.1126/science.1165557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165557</ArticleId><ArticleId IdType="pmc">PMC3923423</ArticleId><ArticleId IdType="pubmed">19213880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J.L., Pham S., Borish L. Rhinovirus and Asthma Exacerbations. Immunol. Allergy Clin. N. Am. 2019;39:335–344. doi: 10.1016/j.iac.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2019.03.003</ArticleId><ArticleId IdType="pmc">PMC6625523</ArticleId><ArticleId IdType="pubmed">31284924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergroth E., Aakula M., Elenius V., Remes S., Piippo-Savolainen E., Korppi M., Piedra P.A., Bochkov Y.A., Gern J.E., Camargo C.A., Jr., et al. Rhinovirus Type in Severe Bronchiolitis and the Development of Asthma. J. Allergy Clin. Immunol. Pract. 2020;8:588–595. doi: 10.1016/j.jaip.2019.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.08.043</ArticleId><ArticleId IdType="pmc">PMC7012669</ArticleId><ArticleId IdType="pubmed">31520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., Gern J.E. Rhinovirus-associated wheeze during infancy and asthma development. Curr. Respir. Med. Rev. 2011;7:160–166. doi: 10.2174/157339811795589423.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157339811795589423</ArticleId><ArticleId IdType="pmc">PMC3469323</ArticleId><ArticleId IdType="pubmed">23066381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox D.W., Khoo S.K., Zhang G., Lindsay K., Keil A.D., Knight G., Gern J.E., Laing I.A., Bizzintino J., Le Souef P.N. Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions. Eur. Respir. J. 2018;52:1800207. doi: 10.1183/13993003.00207-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00207-2018</ArticleId><ArticleId IdType="pmc">PMC6295450</ArticleId><ArticleId IdType="pubmed">29976655</ArticleId></ArticleIdList></Reference><Reference><Citation>Raita Y., Camargo C.A., Jr., Bochkov Y.A., Celedon J.C., Gern J.E., Mansbach J.M., Rhee E.P., Freishtat R.J., Hasegawa K. Integrated-omics endotyping of infants with rhinovirus bronchiolitis and risk of childhood asthma. J. Allergy Clin. Immunol. 2021;147:2108–2117. doi: 10.1016/j.jaci.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC8116357</ArticleId><ArticleId IdType="pubmed">33197460</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Voelker D.R. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2022;1867:159139. doi: 10.1016/j.bbalip.2022.159139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2022.159139</ArticleId><ArticleId IdType="pmc">PMC9050941</ArticleId><ArticleId IdType="pubmed">35240310</ArticleId></ArticleIdList></Reference><Reference><Citation>Voelker D.R., Numata M. Phospholipid regulation of innate immunity and respiratory viral infection. J. Biol. Chem. 2019;294:4282–4289. doi: 10.1074/jbc.AW118.003229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.AW118.003229</ArticleId><ArticleId IdType="pmc">PMC6433062</ArticleId><ArticleId IdType="pubmed">30733339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto M., Asai Y., Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 2003;278:44205–44213. doi: 10.1074/jbc.M306735200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M306735200</ArticleId><ArticleId IdType="pubmed">12947124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandasamy P., Numata M., Berry K.Z., Fickes R., Leslie C.C., Murphy R.C., Voelker D.R. Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling. J. Lipid Res. 2016;57:993–1005. doi: 10.1194/jlr.M065201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M065201</ArticleId><ArticleId IdType="pmc">PMC4878184</ArticleId><ArticleId IdType="pubmed">27095543</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Chu H.W., Dakhama A., Voelker D.R. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc. Natl. Acad. Sci. USA. 2010;107:320–325. doi: 10.1073/pnas.0909361107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0909361107</ArticleId><ArticleId IdType="pmc">PMC2806703</ArticleId><ArticleId IdType="pubmed">20080799</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Kandasamy P., Nagashima Y., Fickes R., Murphy R.C., Voelker D.R. Phosphatidylinositol inhibits respiratory syncytial virus infection. J. Lipid Res. 2015;56:578–587. doi: 10.1194/jlr.M055723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M055723</ArticleId><ArticleId IdType="pmc">PMC4340305</ArticleId><ArticleId IdType="pubmed">25561461</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Nagashima Y., Moore M.L., Berry K.Z., Chan M., Kandasamy P., Peebles R.S., Jr., Murphy R.C., Voelker D.R. Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection. J. Lipid Res. 2013;54:2133–2143. doi: 10.1194/jlr.M037077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M037077</ArticleId><ArticleId IdType="pmc">PMC3708363</ArticleId><ArticleId IdType="pubmed">23749985</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Mitchell J.R., Tipper J.L., Brand J.D., Trombley J.E., Nagashima Y., Kandasamy P., Chu H.W., Harrod K.S., Voelker D.R. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models. J. Biol. Chem. 2020;295:1704–1715. doi: 10.1074/jbc.RA119.012053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.012053</ArticleId><ArticleId IdType="pmc">PMC7008372</ArticleId><ArticleId IdType="pubmed">31882535</ArticleId></ArticleIdList></Reference><Reference><Citation>Everman J.L., Sajuthi S., Saef B., Rios C., Stoner A.M., Numata M., Hu D., Eng C., Oh S., Rodriguez-Santana J., et al. Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J. Allergy Clin. Immunol. 2019;144:962–971. doi: 10.1016/j.jaci.2019.01.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.01.052</ArticleId><ArticleId IdType="pmc">PMC6766426</ArticleId><ArticleId IdType="pubmed">30930175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.M., Wang W., Rueckert R.R. Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes. 1995;9:177–181. doi: 10.1007/BF01702661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01702661</ArticleId><ArticleId IdType="pubmed">7732663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser A.G., Brockman-Schneider R., Amineva S., Burchell L., Sedgwick J.B., Busse W.W., Gern J.E. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J. Infect. Dis. 2002;185:734–743. doi: 10.1086/339339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/339339</ArticleId><ArticleId IdType="pubmed">11920291</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedán A., Swieboda D., Charles M., Toussaint M., Johnston S.L., Asfor A., Panjwani A., Tuthill T.J., Danahay H., Raynham T., et al. Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication. J. Virol. 2017;91:e00217-17. doi: 10.1128/JVI.00217-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00217-17</ArticleId><ArticleId IdType="pmc">PMC5391474</ArticleId><ArticleId IdType="pubmed">28228588</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M., Kandasamy P., Nagashima Y., Posey J., Hartshorn K., Woodland D., Voelker D.R. Phosphatidylglycerol suppresses influenza A virus infection. Am. J. Respir. Cell Mol. Biol. 2012;46:479–487. doi: 10.1165/rcmb.2011-0194OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2011-0194OC</ArticleId><ArticleId IdType="pmc">PMC3359948</ArticleId><ArticleId IdType="pubmed">22052877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y.A., Hanson K.M., Keles S., Brockman-Schneider R.A., Jarjour N.N., Gern J.E. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010;3:69–80. doi: 10.1038/mi.2009.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2009.109</ArticleId><ArticleId IdType="pmc">PMC2884103</ArticleId><ArticleId IdType="pubmed">19710636</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer N., Li X., Seibold M.A., Jarjour N.N., Denlinger L.C., Castro M., Coverstone A.M., Teague W.G., Boomer J., Bleecker E.R., et al. The effect of BPIFA1/SPLUNC1 genetic variation on its expression and function in asthmatic airway epithelium. JCI Insight. 2019;4:e127237. doi: 10.1172/jci.insight.127237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.127237</ArticleId><ArticleId IdType="pmc">PMC6538329</ArticleId><ArticleId IdType="pubmed">30996135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajuthi S.P., Everman J.L., Jackson N.D., Saef B., Rios C.L., Moore C.M., Mak A.C.Y., Eng C., Fairbanks-Mahnke A., Salazar S., et al. Nasal airway transcriptome-wide association study of asthma reveals genetically driven mucus pathobiology. Nat. Commun. 2022;13:1632. doi: 10.1038/s41467-022-28973-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28973-7</ArticleId><ArticleId IdType="pmc">PMC8960819</ArticleId><ArticleId IdType="pubmed">35347136</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson N.D., Everman J.L., Chioccioli M., Feriani L., Goldfarbmuren K.C., Sajuthi S.P., Rios C.L., Powell R., Armstrong M., Gomez J., et al. Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma. Cell Rep. 2020;32:107872. doi: 10.1016/j.celrep.2020.107872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107872</ArticleId><ArticleId IdType="pmc">PMC8046336</ArticleId><ArticleId IdType="pubmed">32640237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Lei R., Ding S.W., Zhu S. Skewer: A fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinform. 2014;15:182. doi: 10.1186/1471-2105-15-182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-182</ArticleId><ArticleId IdType="pmc">PMC4074385</ArticleId><ArticleId IdType="pubmed">24925680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Langmead B., Salzberg S.L. HISAT: A fast spliced aligner with low memory requirements. Nat. Methods. 2015;12:357–360. doi: 10.1038/nmeth.3317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3317</ArticleId><ArticleId IdType="pmc">PMC4655817</ArticleId><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S., Pyl P.T., Huber W. HTSeq—A Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–169. doi: 10.1093/bioinformatics/btu638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkema L., Strobl D., Zappia L., Madissoon E., Markov N., Zaragosi L., Ansari M., Arguel M., Apperloo L., Bécavin C., et al. An integrated cell atlas of the human lung in health and disease. bioRxiv. 2022 doi: 10.1101/2022.03.10.483747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.10.483747</ArticleId></ArticleIdList></Reference><Reference><Citation>Vladar E.K., Brody S.L. Analysis of ciliogenesis in primary culture mouse tracheal epithelial cells. Methods Enzym. 2013;525:285–309. doi: 10.1016/B978-0-12-397944-5.00014-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-397944-5.00014-6</ArticleId><ArticleId IdType="pubmed">23522475</ArticleId></ArticleIdList></Reference><Reference><Citation>Egli A., Santer D.M., O’Shea D., Tyrrell D.L., Houghton M. The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg. Microbes Infect. 2014;3:e51. doi: 10.1038/emi.2014.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.51</ArticleId><ArticleId IdType="pmc">PMC4126180</ArticleId><ArticleId IdType="pubmed">26038748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A., Macintyre J., Edwards M.R., Del Rosario A., Haas J., Gielen V., Kon O.M., McHale M., Johnston S.L. Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax. 2014;69:240–246. doi: 10.1136/thoraxjnl-2012-202909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-202909</ArticleId><ArticleId IdType="pubmed">24127021</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo S.K., Read J., Franks K., Zhang G., Bizzintino J., Coleman L., McCrae C., Oberg L., Troy N.M., Prastanti F., et al. Upper Airway Cell Transcriptomics Identify a Major New Immunological Phenotype with Strong Clinical Correlates in Young Children with Acute Wheezing. J. Immunol. 2019;202:1845–1858. doi: 10.4049/jimmunol.1800178.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800178</ArticleId><ArticleId IdType="pubmed">30745463</ArticleId></ArticleIdList></Reference><Reference><Citation>Roulin P.S., Lotzerich M., Torta F., Tanner L.B., van Kuppeveld F.J., Wenk M.R., Greber U.F. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe. 2014;16:677–690. doi: 10.1016/j.chom.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.10.003</ArticleId><ArticleId IdType="pubmed">25525797</ArticleId></ArticleIdList></Reference><Reference><Citation>Strating J.R., van Kuppeveld F.J. Viral rewiring of cellular lipid metabolism to create membranous replication compartments. Curr. Opin. Cell Biol. 2017;47:24–33. doi: 10.1016/j.ceb.2017.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2017.02.005</ArticleId><ArticleId IdType="pmc">PMC7127510</ArticleId><ArticleId IdType="pubmed">28242560</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar H.M., Dorobantu C.M., Albulescu L., Strating J., van Kuppeveld F.J.M. Fat(al) attraction: Picornaviruses Usurp Lipid Transfer at Membrane Contact Sites to Create Replication Organelles. Trends Microbiol. 2016;24:535–546. doi: 10.1016/j.tim.2016.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.02.017</ArticleId><ArticleId IdType="pmc">PMC7126954</ArticleId><ArticleId IdType="pubmed">27020598</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrae C., Dzgoev A., Stahlman M., Horndahl J., Svard R., Grosse A., Grosskopf T., Skujat M.A., Williams N., Schubert S., et al. Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2018;59:713–722. doi: 10.1165/rcmb.2017-0438OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2017-0438OC</ArticleId><ArticleId IdType="pubmed">30084659</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhail J.A., Burke J.E. Molecular mechanisms of PI4K regulation and their involvement in viral replication. Traffic. 2022;24:131–145. doi: 10.1111/tra.12841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12841</ArticleId><ArticleId IdType="pubmed">35579216</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M., Geiser J., Huang S., Constant S., Kaiser L., Tapparel C. Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia. Sci. Rep. 2020;10:10246. doi: 10.1038/s41598-020-66748-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66748-6</ArticleId><ArticleId IdType="pmc">PMC7314816</ArticleId><ArticleId IdType="pubmed">32581261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Tang W., Ray A., Wu Y., Einarsson O., Landry M.L., Gwaltney J., Jr., Elias J.A. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Investig. 1996;97:421–430. doi: 10.1172/JCI118431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118431</ArticleId><ArticleId IdType="pmc">PMC507033</ArticleId><ArticleId IdType="pubmed">8567963</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunberg K., Smits H.H., Timmers M.C., de Klerk E.P., Dolhain R.J., Dick E.C., Hiemstra P.S., Sterk P.J. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am. J. Respir. Crit. Care Med. 1997;156:609–616. doi: 10.1164/ajrccm.156.2.9610079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.156.2.9610079</ArticleId><ArticleId IdType="pubmed">9279247</ArticleId></ArticleIdList></Reference><Reference><Citation>Foxman E.F., Storer J.A., Vanaja K., Levchenko A., Iwasaki A. Two interferon-independent double-stranded RNA-induced host defense strategies suppress the common cold virus at warm temperature. Proc. Natl. Acad. Sci. USA. 2016;113:8496–8501. doi: 10.1073/pnas.1601942113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1601942113</ArticleId><ArticleId IdType="pmc">PMC4968739</ArticleId><ArticleId IdType="pubmed">27402752</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 2009;183:6989–6997. doi: 10.4049/jimmunol.0901386.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901386</ArticleId><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiner C.A., Jackson W.T. Fragmentation of the Golgi apparatus provides replication membranes for human rhinovirus 1A. Virology. 2010;407:185–195. doi: 10.1016/j.virol.2010.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.08.012</ArticleId><ArticleId IdType="pmc">PMC7111317</ArticleId><ArticleId IdType="pubmed">20825962</ArticleId></ArticleIdList></Reference><Reference><Citation>Glingston R.S., Deb R., Kumar S., Nagotu S. Organelle dynamics and viral infections: At cross roads. Microbes Infect. 2019;21:20–32. doi: 10.1016/j.micinf.2018.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2018.06.002</ArticleId><ArticleId IdType="pmc">PMC7110583</ArticleId><ArticleId IdType="pubmed">29953921</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudernak E., Seipelt J., Triendl A., Grassauer A., Kuechler E. Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. J. Virol. 2002;76:6004–6015. doi: 10.1128/JVI.76.12.6004-6015.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.12.6004-6015.2002</ArticleId><ArticleId IdType="pmc">PMC136215</ArticleId><ArticleId IdType="pubmed">12021333</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai A.W., Bojjireddy N., Balla T. A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases. Anal. Biochem. 2011;417:97–102. doi: 10.1016/j.ab.2011.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2011.05.046</ArticleId><ArticleId IdType="pmc">PMC3143478</ArticleId><ArticleId IdType="pubmed">21704602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa-Sasaki K., Nagashima S., Taniguchi K., Sasaki J. Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1. J. Virol. 2018;92:e01952-17. doi: 10.1128/JVI.01952-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01952-17</ArticleId><ArticleId IdType="pmc">PMC5874406</ArticleId><ArticleId IdType="pubmed">29367253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nchoutmboube J., Ford-Siltz L.A., Belov G.A. Enterovirus replication: Go with the (counter) flow. Trends Microbiol. 2015;23:183–184. doi: 10.1016/j.tim.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.02.008</ArticleId><ArticleId IdType="pubmed">25748799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo H., van der Schaar H.M., Dorobantu C.M., Rabouw H.H., Strating J.R., Van Kuppeveld F.J. ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB. mBio. 2019;10:e02742-18. doi: 10.1128/mBio.02742-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02742-18</ArticleId><ArticleId IdType="pmc">PMC6372799</ArticleId><ArticleId IdType="pubmed">30755512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilnytska O., Santiana M., Hsu N.Y., Du W.L., Chen Y.H., Viktorova E.G., Belov G., Brinker A., Storch J., Moore C., et al. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe. 2013;14:281–293. doi: 10.1016/j.chom.2013.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.08.002</ArticleId><ArticleId IdType="pmc">PMC3802520</ArticleId><ArticleId IdType="pubmed">24034614</ArticleId></ArticleIdList></Reference><Reference><Citation>Roulin P.S., Murer L.P., Greber U.F. A single point mutation in the rhinovirus 2B protein reduces the requirement for phosphatidylinositol 4-kinase class III beta in viral replication. J. Virol. 2018;92:e01462-18. doi: 10.1128/JVI.01462-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01462-18</ArticleId><ArticleId IdType="pmc">PMC6232462</ArticleId><ArticleId IdType="pubmed">30209171</ArticleId></ArticleIdList></Reference><Reference><Citation>Potaczek D.P., Unger S.D., Zhang N., Taka S., Michel S., Akdag N., Lan F., Helfer M., Hudemann C., Eickmann M., et al. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J. Allergy Clin. Immunol. 2019;143:1403–1415. doi: 10.1016/j.jaci.2018.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.07.026</ArticleId><ArticleId IdType="pubmed">30114391</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipps K.M., Martinez A., Lu J., Heinz B.A., Zhao G. Small interfering RNA molecules as potential anti-human rhinovirus agents: In vitro potency, specificity, and mechanism. Antivir. Res. 2004;61:49–55. doi: 10.1016/j.antiviral.2003.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2003.08.005</ArticleId><ArticleId IdType="pubmed">14670593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>